2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
18
Carcinoma, Non-Small-Cell Lung
14
Colorectal Neoplasms
11
Lung Neoplasms
9
Recurrence
7
Neoplasm Metastasis
5
Colonic Neoplasms
5
Breast Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Infertility
4
Neoplasms
3
Lymphoma, T-Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Papillomavirus Infections
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Insulin Resistance
2
Infertility, Female
2
Hyperandrogenism
2
Head and Neck Neoplasms
2
Diabetes, Gestational
2
Carcinoma, Transitional Cell
2
Atypical Squamous Cells of the Cervix
2
Interventions
Radiotherapy
9
Cisplatin
8
Fibroblast Growth Factor 7
6
Low-Level Light Therapy
5
angiotensin I (1-7)
4
Radiation
4
Injections
4
Propolis
3
Morphine
3
Methotrexate
3
Leucovorin
3
Drug Therapy
3
Cryotherapy
3
glucarpidase
2
aluminum hydroxide, magnesium hydroxide, drug combination
2
Xylitol
2
Water
2
Radiotherapy, Intensity-Modulated
2
RRx-001
2
Probiotics
2
Pentoxifylline
2
Mouthwashes
2
Melphalan
2
Lidocaine
2
Ketamine
2
Interleukin 1 Receptor Antagonist Protein
2
Honey
2
Glutamine
2
Gabapentin
2
Fluorouracil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mucositis
×
Folic Acid
×
Clear all
NCT03581773
2026-05-04
DARENCA4
University of Aarhus
Phase 2
Recruiting
100 enrolled